Study guide
4.2 Dosage Calculations and Intravenous Therapy
QCHP/DHP Qualifying Examination - Nurse Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Preparation Strategy
1.1 About the Qatar DHP Nurse Qualifying Exam 1.2 Test-Taking Strategies & Clinical Judgment for Prometric MCQs
2 Chapter 2: Fundamentals of Nursing Practice & Patient Safety
2.1 Infection Prevention, Control, and Aseptic Technique 2.2 Vital Signs, Patient Assessment, and Clinical Documentation 2.3 Patient Safety, Mobility, and Pressure Injury Prevention
3 Chapter 3: Core Nursing Skills: Oxygenation, Nutrition, Elimination & Diagnostics
3.1 Oxygen Delivery, Airway Clearance, and Tracheostomy Care 3.2 Nutrition Screening, Dysphagia, and Feeding-Tube Nursing 3.3 Urinary and Bowel Elimination, Catheter Care, and Ostomy Management 3.4 Specimen Collection, Point-of-Care Testing, and Diagnostic Preparation
4 Chapter 4: Clinical Pharmacology, Calculations & Fluid Balance
4.1 Principles of Safe Medication Administration 4.2 Dosage Calculations and Intravenous Therapy 4.3 Fluid, Electrolyte, and Acid-Base Balance
5 Chapter 5: Adult Cardiovascular, Vascular & Hematologic Nursing
5.1 Acute Coronary Syndromes and Heart Failure Management 5.2 Dysrhythmias, ECG Interpretation, and Shock States 5.3 Peripheral Vascular Disease, Venous Thromboembolism, and Anticoagulation Safety 5.4 Hematology, Anemias, and Blood Component Therapy
6 Chapter 6: Adult Respiratory & Endocrine Nursing
6.1 Chronic and Acute Respiratory Disorders 6.2 Mechanical Ventilation and Critical Respiratory Care 6.3 Diabetes Mellitus and Endocrine Emergencies
7 Chapter 7: Adult Gastrointestinal, Renal & Neurological Nursing
7.1 Gastrointestinal Disorders, Nutrition, and Hepatic Disease 7.2 Renal Disorders, Dialysis, and Fluid Homeostasis 7.3 Neurological Emergencies and Neuromuscular Disorders
8 Chapter 8: Adult Perioperative, Musculoskeletal & Mental Health Nursing
8.1 Perioperative Nursing and Wound Care Management 8.2 Musculoskeletal Care, Trauma, and Burn Management 8.3 Psychiatric and Mental Health Nursing
9 Chapter 9: Adult Oncology, Infectious Disease & Immune Disorders
9.1 Oncology Nursing and Oncologic Emergencies 9.2 Sepsis, Tuberculosis, HIV, and Multidrug-Resistant Organisms 9.3 Immune, Rheumatologic, and Connective Tissue Disorders
10 Chapter 10: Adult Sensory, Integumentary & Gerontological Nursing
10.1 Eye, Ear, and Integumentary Disorders 10.2 Gerontological Nursing and Care of the Older Adult
11 Chapter 11: Pain, Palliative Care & Community Health Nursing
11.1 Pain Management, Palliative Care, and End-of-Life Nursing 11.2 Community, Public Health, and Home Health Nursing
12 Chapter 12: Antepartum & Intrapartum Nursing Care
12.1 Antepartum Health, Prenatal Assessment, and Screening 12.2 Hypertensive Disorders and High-Risk Pregnancy Complications 12.3 Intrapartum Management and Electronic Fetal Monitoring 12.4 Labor Analgesia, Induction, and Operative Birth
13 Chapter 13: Postpartum & Newborn Nursing Care
13.1 Postpartum Assessment, Care, and Complications 13.2 Normal Newborn Assessment and Transition to Extrauterine Life 13.3 High-Risk Neonatal Conditions and Emergency Management
14 Chapter 14: Pediatric Nursing Care
14.1 Pediatric Growth, Development, and Health Promotion 14.2 Pediatric Respiratory and Infectious Illnesses 14.3 Pediatric Fluid, Electrolyte, and Gastrointestinal Disorders
15 Chapter 15: Pediatric Cardiac, Hematologic & Neurologic Conditions
15.1 Pediatric Cardiac and Congenital Heart Disorders 15.2 Pediatric Hematologic and Oncologic Disorders 15.3 Pediatric Neurologic, Musculoskeletal, and Endocrine Conditions
16 Chapter 16: Women's Health & Family-Centered Pediatric Care
16.1 Women's Health, Family Planning, and Gynecologic Care 16.2 Family-Centered Care, Pediatric Medication Safety, and Child Protection
17 Chapter 17: Unit Management, Leadership & Qatar Healthcare Ethics
17.1 Nursing Leadership, Delegation, and Prioritization 17.2 Interprofessional Communication and Patient Safety 17.3 Healthcare Ethics, Legal Practice, and Qatar Regulation
18 Chapter 18: Quality, Staffing & Emergency Preparedness
18.1 Quality Improvement, Risk Management, and Accreditation 18.2 Staffing, Conflict Management, Change Leadership, and Emergency Preparedness
4.2 Dosage Calculations and Intravenous Therapy
Key Takeaways Explain This Topic AI
Applying dimensional analysis and the desired-over-have formula ensures error-free metric conversions across micrograms, milligrams, grams, and liters.
Powder reconstitution requires accounting for displacement volume, noting that diluent volume added is less than total solution volume.
Infusion rates must be calculated precisely: electronic volumetric pumps operate in milliliters per hour (mL/hr), whereas gravity infusion sets depend on tubing drop factors (gtt/min).
Peripheral IV complications must be systematically differentiated: cold, pale swelling indicates infiltration or vesicant extravasation, while erythema, warmth, and tracking cords indicate phlebitis.
Last updated: September 2026
4.2 Dosage Calculations and Intravenous Therapy
Precise mathematical calculation of drug dosages and intravenous flow rates is an essential competency for safe nursing practice. Dosage calculation errors can result in catastrophic underdosing (leading to therapeutic failure) or toxic overdosing (inducing organ failure or death). Registered nurses must possess absolute mastery over metric unit conversions, oral and parenteral calculation formulas, powder reconstitution, pediatric weight-based regimens, and intravenous line surveillance.
Metric Unit Conversions and Basic Dosage Formulas
Clinical calculations require fluid movement between metric units of mass, volume, and household equivalents. The nurse must memorize and execute the standard conversion factors without hesitation.
Measurement Dimension Fundamental Metric Conversion Factors Household to Metric Equivalents
Mass (Weight) 1 kilogram (kg) = 1,000 grams (g) 1\text{ kilogram (kg)} = 1{,}000\text{ grams (g)} 1 kilogram (kg) = 1 , 000 grams (g) ; 1 gram (g) = 1,000 milligrams (mg) 1\text{ gram (g)} = 1{,}000\text{ milligrams (mg)} 1 gram (g) = 1 , 000 milligrams (mg) ; 1 milligram (mg) = 1,000 micrograms (mcg) 1\text{ milligram (mg)} = 1{,}000\text{ micrograms (mcg)} 1 milligram (mg) = 1 , 000 micrograms (mcg) 1 kilogram (kg) = 2.2 pounds (lb) 1\text{ kilogram (kg)} = 2.2\text{ pounds (lb)} 1 kilogram (kg) = 2.2 pounds (lb) ; 1 pound (lb) = 16 ounces (oz) 1\text{ pound (lb)} = 16\text{ ounces (oz)} 1 pound (lb) = 16 ounces (oz)
Volume (Liquid) 1 Liter (L) = 1,000 milliliters (mL) 1\text{ Liter (L)} = 1{,}000\text{ milliliters (mL)} 1 Liter (L) = 1 , 000 milliliters (mL) ; 1 milliliter (mL) = 1 cubic centimeter (cc) 1\text{ milliliter (mL)} = 1\text{ cubic centimeter (cc)} 1 milliliter (mL) = 1 cubic centimeter (cc) 1 teaspoon (tsp) = 5 mL 1\text{ teaspoon (tsp)} = 5\text{ mL} 1 teaspoon (tsp) = 5 mL ; 1 tablespoon (tbsp) = 15 mL = 3 tsp 1\text{ tablespoon (tbsp)} = 15\text{ mL} = 3\text{ tsp} 1 tablespoon (tbsp) = 15 mL = 3 tsp ; 1 fluid ounce (fl oz) = 30 mL = 2 tbsp 1\text{ fluid ounce (fl oz)} = 30\text{ mL} = 2\text{ tbsp} 1 fluid ounce (fl oz) = 30 mL = 2 tbsp ; 1 measuring cup = 8 fl oz = 240 mL 1\text{ measuring cup} = 8\text{ fl oz} = 240\text{ mL} 1 measuring cup = 8 fl oz = 240 mL
Clinical Notation Rules
Leading Zeros: Always place a leading zero before a decimal point when the number is less than one (e.g., write 0.5 mg , never .5 mg ). This prevents the decimal from being overlooked, which would result in a ten-fold overdose.
Trailing Zeros: Never attach a trailing zero after a whole number or decimal (e.g., write 5 mg , never 5.0 mg ). If the decimal point fades or prints poorly, 5.0 mg can be misread as 50 mg.
The Desired-Over-Have (D/H x V) Formula
The most widely utilized clinical calculation tool is the Desired-Over-Have equation: Volume or Tablets to Administer = Desired Dose (D) Dose on Hand (H) × Vehicle Volume or Quantity (V) \text{Volume or Tablets to Administer} = \frac{\text{Desired Dose (D)}}{\text{Dose on Hand (H)}} \times \text{Vehicle Volume or Quantity (V)} Volume or Tablets to Administer = Dose on Hand (H) Desired Dose (D) × Vehicle Volume or Quantity (V)
Where:
Desired (D): The exact dose ordered by the prescriber (must be in identical units as Hand).
Have (H): The strength or dosage of the medication available in stock.
Vehicle (V): The form and volume containing the on-hand dose (e.g., 1 tablet, 1 capsule, 2 mL, 5 mL).
Worked Clinical Example: A physician prescribes furosemide 60 mg IV push. The pharmacy supplies furosemide injection labeled 40 mg / 4 mL. Volume = 60 mg 40 mg × 4 mL = 1.5 × 4 mL = 6 mL \text{Volume} = \frac{60\text{ mg}}{40\text{ mg}} \times 4\text{ mL} = 1.5 \times 4\text{ mL} = 6\text{ mL} Volume = 40 mg 60 mg × 4 mL = 1.5 × 4 mL = 6 mL
Reconstitution of Powdered Medications
Certain pharmacological agents (such as parenteral penicillin, cefazolin, and methylprednisolone) are unstable in liquid solution over extended periods. Manufacturers package these drugs as dry, sterile powders requiring reconstitution with a sterile liquid diluent prior to administration.
Terminology of Reconstitution
Solute: The dry, concentrated powdered drug in the sterile vial.
Diluent: The liquid added to dissolve the powder (typically sterile water for injection, 0.9% sodium chloride, or bacteriostatic water).
Solution: The resulting liquid medication ready for withdrawal and administration.
Displacement Volume: The powder itself occupies physical volume. When diluent is introduced, the resulting total volume exceeds the added liquid volume. For example, adding 4.3 mL of diluent to a powdered vial may yield a total volume of 5.0 mL. Therefore, calculations must always be based on the final resultant concentration stated on the manufacturer label , never solely on the amount of diluent injected.
Step-by-Step Reconstitution Protocol
Inspect the vial for powder integrity, seal seal, and expiration date.
Read the label instructions to identify: (a) type of diluent required, (b) exact volume of diluent to inject, (c) resultant concentration per milliliter, and (d) post-reconstitution storage temperature and stability lifespan.
Using aseptic technique, inject the specified diluent into the vial.
Gently roll and swirl the vial between palms until the powder completely dissolves. Never shake vigorously, which causes foaming and protein denaturation.
Inspect the final solution for clarity, precipitates, or discoloration.
Affix a label to the vial indicating: date and time of reconstitution, final concentration, expiration date/time, and the nurse's initials.
Intravenous Infusion Flow Rate Calculations
Intravenous solutions and medications are delivered either via electronic volumetric infusion pumps or gravity administration sets.
1. Electronic Volumetric Infusion Pumps (mL/hr)
Volumetric smart pumps deliver fluids in milliliters per hour (mL/hr). When the order specifies a volume to be infused over a given number of hours, the formula is: Pump Rate (mL/hr) = Total Volume to Infuse (mL) Total Infusion Time (hours) \text{Pump Rate (mL/hr)} = \frac{\text{Total Volume to Infuse (mL)}}{\text{Total Infusion Time (hours)}} Pump Rate (mL/hr) = Total Infusion Time (hours) Total Volume to Infuse (mL)
If the prescriber orders a volume to infuse over a specified number of minutes (e.g., an antibiotic piggyback over 30 or 45 minutes), calculate the rate using: Pump Rate (mL/hr) = Volume (mL) Time in Minutes × 60 min/hr \text{Pump Rate (mL/hr)} = \frac{\text{Volume (mL)}}{\text{Time in Minutes}} \times 60\text{ min/hr} Pump Rate (mL/hr) = Time in Minutes Volume (mL) × 60 min/hr
Worked Clinical Example: Prescribed: Metronidazole 500 mg in 100 mL 0.9% NS IV piggyback to infuse over 40 minutes. Pump Rate = 100 mL 40 min × 60 = 2.5 × 60 = 150 mL/hr \text{Pump Rate} = \frac{100\text{ mL}}{40\text{ min}} \times 60 = 2.5 \times 60 = 150\text{ mL/hr} Pump Rate = 40 min 100 mL × 60 = 2.5 × 60 = 150 mL/hr
2. Gravity Infusion Tubing Drip Rates (gtt/min)
When electronic infusion pumps are unavailable, fluid rates are controlled manually by counting drops falling through the drip chamber per minute using a roller clamp. The drip rate depends entirely on the calibrated drop factor (drops per milliliter, gtt/mL) printed on the administration set packaging: Flow Rate (gtt/min) = Total Volume (mL) × Drop Factor (gtt/mL) Time in Minutes \text{Flow Rate (gtt/min)} = \frac{\text{Total Volume (mL)} \times \text{Drop Factor (gtt/mL)}}{\text{Time in Minutes}} Flow Rate (gtt/min) = Time in Minutes Total Volume (mL) × Drop Factor (gtt/mL)
Administration Tubing Type Drop Factor Calibration Clinical Application & Target Patients
Macrodrip Tubing 10 gtt/mL Routine adult fluid resuscitation, rapid boluses, viscous blood component infusions.
Macrodrip Tubing 15 gtt/mL Standard general adult maintenance infusions and surgical hydration.
Macrodrip Tubing 20 gtt/mL General adult medical-surgical maintenance fluid administration.
Microdrip Tubing 60 gtt/mL Pediatric infusions, neonatal care, and critical care where rates are low and require extreme precision. Rule of thumb: For 60 gtt/mL tubing, mL/hr is mathematically identical to gtt/min.
Worked Clinical Example: Infuse 1,000 mL of Ringer's Lactate over 6 hours using a macrodrip set calibrated to 20 gtt/mL.
Convert hours to minutes: 6 hours × 60 min/hr = 360 minutes 6\text{ hours} \times 60\text{ min/hr} = 360\text{ minutes} 6 hours × 60 min/hr = 360 minutes .
Calculate drip rate: Rate = 1,000 mL × 20 gtt/mL 360 min = 20,000 360 = 55.55 ≈ 56 gtt/min \text{Rate} = \frac{1{,}000\text{ mL} \times 20\text{ gtt/mL}}{360\text{ min}} = \frac{20{,}000}{360} = 55.55 \approx 56\text{ gtt/min} Rate = 360 min 1 , 000 mL × 20 gtt/mL = 360 20 , 000 = 55.55 ≈ 56 gtt/min
Secondary / Piggyback Infusion Mechanics
Intermittent secondary infusions (IVPB) must be hung higher than the primary maintenance bag on an extension hanger. Hydrostatic pressure from the elevated secondary bag forces the one-way back-check valve on the primary tubing to close, allowing only the secondary medication to infuse. Once the secondary container empties, the back-check valve reopens, and primary maintenance fluid resumes automatically.
Pediatric Weight-Based Dosage Calculations
Because pediatric organ clearance and distribution volumes vary dramatically across development, pediatric dosages are individualized based on body weight in kilograms (mg/kg) or body surface area (BSA in m 2 \text{m}^2 m 2 ). The nurse must execute a three-step validation for every pediatric prescription:
Convert Weight: Convert body weight accurately from pounds to kilograms ( 1 kg = 2.2 lb 1\text{ kg} = 2.2\text{ lb} 1 kg = 2.2 lb , rounding to tenths).
Calculate Dose: Multiply weight in kilograms by the prescribed dosage parameter (mg/kg/dose or mg/kg/day).
Validate Safe Range: Cross-reference the calculated dose against standard pediatric drug references (minimum safe dose to maximum safe dose). If the prescribed dose falls outside the safe parameters, withhold the medication and contact the prescriber immediately.
Comprehensive Worked Example: A 3-year-old child weighing 33 lb is prescribed amoxicillin oral suspension for acute otitis media. The prescription reads: Amoxicillin 40 mg/kg/day divided into equal doses every 8 hours. The pharmacy supplies amoxicillin suspension 125 mg / 5 mL. Standard reference safe range: 25 to 50 mg/kg/day.
Step 1 (Weight Conversion): 33 lb ÷ 2.2 = 15 kg 33\text{ lb} \div 2.2 = 15\text{ kg} 33 lb ÷ 2.2 = 15 kg .
Step 2 (Safe Range Validation):
Minimum safe daily dose: 15 kg × 25 mg/kg/day = 375 mg/day 15\text{ kg} \times 25\text{ mg/kg/day} = 375\text{ mg/day} 15 kg × 25 mg/kg/day = 375 mg/day .
Maximum safe daily dose: 15 kg × 50 mg/kg/day = 750 mg/day 15\text{ kg} \times 50\text{ mg/kg/day} = 750\text{ mg/day} 15 kg × 50 mg/kg/day = 750 mg/day .
Prescribed daily dose: 15 kg × 40 mg/kg/day = 600 mg/day 15\text{ kg} \times 40\text{ mg/kg/day} = 600\text{ mg/day} 15 kg × 40 mg/kg/day = 600 mg/day (Falls safely within therapeutic parameters).
Step 3 (Single Dose Calculation):
Doses per day: Every 8 hours ( 24 ÷ 8 = 3 doses/day 24 \div 8 = 3\text{ doses/day} 24 ÷ 8 = 3 doses/day ).
Dose per administration: 600 mg/day ÷ 3 = 200 mg/dose 600\text{ mg/day} \div 3 = 200\text{ mg/dose} 600 mg/day ÷ 3 = 200 mg/dose .
Step 4 (Volume to Administer): Volume = 200 mg 125 mg × 5 mL = 1.6 × 5 mL = 8 mL per dose \text{Volume} = \frac{200\text{ mg}}{125\text{ mg}} \times 5\text{ mL} = 1.6 \times 5\text{ mL} = 8\text{ mL per dose} Volume = 125 mg 200 mg × 5 mL = 1.6 × 5 mL = 8 mL per dose
Peripheral IV Site Assessment, Complications & Management
Peripheral intravenous lines require continuous surveillance to intercept localized mechanical, chemical, and infectious complications before irreversible tissue destruction occurs.
Clinical Complication Pathophysiology & Etiology Key Signs & Symptoms Immediate Nursing Interventions
Infiltration Leakage of a non-vesicant intravenous solution or medication into the surrounding subcutaneous tissue space due to cannula dislodgement or vein perforation. Skin blanching, localized edema, coolness to touch around insertion site, taut stretched skin, sluggish or halted IV flow, discomfort or dull ache. 1. Stop infusion immediately.; 2. Discontinue and remove the catheter.; 3. Elevate the extremity to encourage venous drainage.; 4. Apply a warm compress (for isotonic/alkaline solutions) or cold compress (to reduce edema).; 5. Re-site the IV cannula in the opposite extremity if therapy continues.
Extravasation Infiltration of a vesicant solution or medication into perivascular tissues, triggering severe ischemic cellular necrosis, blistering, and deep tissue sloughing. Examples: norepinephrine, dopamine, vasopressin, concentrated potassium, calcium chloride, and cytotoxic anthracyclines (doxorubicin). Severe burning pain, stinging, blanching followed by dark discoloration, severe localized edema, tightness, absent blood return. 1. Stop the infusion immediately. ; 2. Do NOT immediately remove the cannula. ; 3. Aspirate residual drug and blood from the cannula lumen.; 4. Administer specific local antidote through the cannula if indicated (e.g., phentolamine for catecholamines; hyaluronidase for vinca alkaloids).; 5. Remove the catheter without applying pressure.; 6. Elevate extremity, photograph site, and notify provider.
Phlebitis Inflammation of the internal vein tunica intima caused by mechanical trauma (catheter movement), chemical irritation (acidic, alkaline, or hypertonic infusates), or bacterial colonization. Erythema, warmth, tenderness along the vein pathway, localized edema, palpable venous cord, purulent exudate at puncture site. 1. Discontinue the IV infusion immediately.; 2. Remove the catheter.; 3. Apply warm, moist compresses to relieve inflammation and discomfort.; 4. Document phlebitis grade using the INS scale.; 5. Culture the insertion site and catheter tip if purulence is present.
The Infusion Nurses Society (INS) Phlebitis Grading Scale
Grade 0: No symptoms; insertion site is healthy and quiet.
Grade 1: Erythema at insertion site with or without pain.
Grade 2: Pain at insertion site with erythema and/or edema.
Grade 3: Pain at insertion site with erythema, edema, streak formation, and a palpable venous cord.
Grade 4: Pain at insertion site with erythema, edema, streak formation, palpable venous cord greater than 1 inch (2.5 cm) in length, and purulent drainage.